Abstract:Antimicrobial resistance poses a significant threat to humanity, and the development of new antibiotics is urgently needed. Our research has focused on thiopeptide antibiotics such as micrococcin P2 (MP2) and derivatives thereof as new anti-infective agents. Thiopeptides are sulfur-rich, structurally complex substances that exhibit potent activity against Gram-positive pathogens and Mycobacteria species, including clinically resistant strains. The clinical development of thiopeptides has been hampered by the lack of efficient synthetic platforms to conduct detailed structure-activity relationship studies of these natural products. The present contribution touches upon efficient synthetic routes to MP2 that laid the groundwork for clinical translation. The medicinal chemistry campaign on MP2 has been guided by computational molecular dynamic simulations and parallel investigations to improve drug-like properties, such as enhancing the aqueous solubility and optimizing antibacterial activity. Such endeavors have enabled identification of promising lead compounds, AJ-037 and AJ-206, against Mycobacterium avium complex (MAC). Extensive in vitro studies revealed that these compounds exert potent activity against MAC species, a subspecies of non-tuberculous mycobacteria (NTM) that proliferate inside macrophages. Two additional pre-clinical candidates have been identified: AJ-024, for the treatment of Clostridioides difficile infections, and AJ-147, for methicillin-resistant Staphylococcus aureus impetigo. Both compounds compare quite favorably with current first-line treatments. In particular, the ability of AJ-147 to downregulate pro-inflammatory cytokines adds a valuable dimension to its clinical use. In light of above, these new thiopeptide derivatives are well-poised for further clinical development.

Progress in Synthesis of Thiopeptide Antibiotics Analogues

Research Progress in Chemical Semi-synthetic Modification of Thiopeptide Antibiotics

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Target-Oriented Design and Biosynthesis of Thiostrepton-Derived Thiopeptide Antibiotics with Improved Pharmaceutical Properties

Discovery and Efficient Synthesis of a Biologically Active Alkaloid Inspired by Thiostrepton Biosynthesis

Mutasynthesis Generates Antibacterial Benzothiophenic-Containing Nosiheptide Analogues

Biosynthesis of Thiopeptide Antibiotics and Their Pathway Engineering

Recent Developments in the Synthesis of N-aryl Sulfonamides

Sulfur-containing peptides: Synthesis and application in the discovery of potential drug candidates

Thiopeptide Biosynthesis Featuring Ribosomally Synthesized Precursor Peptides and Conserved Posttranslational Modifications

Synthesis of sulfonopeptides

Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides

Towards the Development of Synthetic Antibiotics: Designs Inspired by Natural Antimicrobial Peptides

Using chemical synthesis to optimise antimicrobial peptides in the fight against antimicrobial resistance

Semisynthesis: An Essential Tool for Antibiotics Drug Discovery

Current synthetic chemistry towards cyclic antimicrobial peptides

Towards More Practical Methods for the Chemical Synthesis of Thioamides Using Sulfuration Agents: A Decade Update

Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics

Overcoming Antibiotic Resistance Through Efficient and Scalable Total Synthesis

Diaminodiacid-based solid-phase synthesis of peptide disulfide bond mimics.

Contemporary Applications of Thioamides and Methods for their Synthesis